Arkolith/Insider Trading/HILS/Form 4

Milby Randy

Chief Executive Officer, DirectorHillstream BioPharma Inc. (HILS) · full profile →Form 4 · filed May 25, 2022
Net Buying
Open-Market Buys
$786
Open-Market Sells
$0
Net Open-Market Flow
$786
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 25, 2022Buy(P)200$0.77$1542.9M
May 25, 2022Buy(P)800$0.79$6322.9M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-015080) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML